Finding the Optimal Location for Saturation Measurement During Flexible Bronchoscopy
Optimal Location of Saturation Measurement During Flexible Fiberoptic Bronchoscopy
1 other identifier
observational
116
1 country
1
Brief Summary
An observational comparison of different locations of saturation measurements during Flexible Bronchoscopy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 31, 2017
CompletedFirst Posted
Study publicly available on registry
February 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2017
CompletedMarch 31, 2017
March 1, 2017
3 months
January 31, 2017
March 30, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Value changes between locations
Difference of 10% of blood saturation between different locations during sedation for bronchoscopy procedure.
Through completion of bronchoscopy procedure an average of 30 minutes
Time changes between locations
The level of desaturation of 90% is checked in the different monitors and the gap in seconds is registered
Through completion of bronchoscopy procedure an average of 30 minutes
Secondary Outcomes (1)
gap between arterial gas sample and different monitors
Through completion of bronchoscopy procedure an average of 30 minutes
Interventions
Eligibility Criteria
100 patients, adults, undergoing Flexible Fiberoptic Bronchoscopy under sedation
You may qualify if:
- informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pulmonary Institute Rabin Medical Center
Petah Tikva, 49100, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mordechai R Kramer, MD
Rabin Medical Center, Belinson Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Pulmonary Institute
Study Record Dates
First Submitted
January 31, 2017
First Posted
February 23, 2017
Study Start
January 1, 2017
Primary Completion
March 30, 2017
Study Completion
March 30, 2017
Last Updated
March 31, 2017
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will not share